151 related articles for article (PubMed ID: 8490540)
1. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany.
Wahrendorf J; Robra BP; Wiebelt H; Oberhausen R; Weiland M; Dhom G
Eur J Cancer Prev; 1993 May; 2(3):221-7. PubMed ID: 8490540
[TBL] [Abstract][Full Text] [Related]
2. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
[TBL] [Abstract][Full Text] [Related]
3. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
[TBL] [Abstract][Full Text] [Related]
4. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
Tong S; Hughes K; Oldenburg B; Del Mar C
Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate colorectal cancer screening: findings and implications.
Fisher DA; Judd L; Sanford NS
Am J Gastroenterol; 2005 Nov; 100(11):2526-30. PubMed ID: 16279910
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
Yu H
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case-control study.
Tsukada H; Kurita Y; Yokoyama A; Wakai S; Nakayama T; Sagawa M; Misawa H
Br J Cancer; 2001 Nov; 85(9):1326-31. PubMed ID: 11720469
[TBL] [Abstract][Full Text] [Related]
9. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
12. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
Loss J; Eichhorn C; Nagel E
Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
[TBL] [Abstract][Full Text] [Related]
14. [An applied study on the method of multi-factorial quantitative-risk assessment (MFQRA) for mass screening of colorectal cancer].
Chen K
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):37-40. PubMed ID: 8334938
[TBL] [Abstract][Full Text] [Related]
15. [Knowledge of colorectal cancer prevention in the Bavarian population above 50 years--survey in two districts].
Loss J; Eichhorn C; Nagel E
Gesundheitswesen; 2005 Jul; 67(7):455-60. PubMed ID: 16103968
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
Strul H; Elyakim R; Halpern Z; Arber N
Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
[TBL] [Abstract][Full Text] [Related]
18. Patient compliance with colorectal cancer screening in general practice.
Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
[TBL] [Abstract][Full Text] [Related]
19. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.
Schoen RE; Weissfeld JL; Trauth JM; Ling BS; Hayran M
Am J Gastroenterol; 2002 Feb; 97(2):446-51. PubMed ID: 11866286
[TBL] [Abstract][Full Text] [Related]
20. [Screening for cancer of the large intestine].
Gnauck R
Wien Med Wochenschr; 1988 Jun; 138(11-12):257-60. PubMed ID: 3051684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
